These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 18405083)

  • 1. Magnetic resonance spectroscopy and measurement of tau epitopes of autopsy proven sporadic Creutzfeldt-Jakob disease in a patient with non-specific initial EEG, MRI and negative 14-3-3 immunoblot.
    Sarac H; Hajnsek S; Basić S; Henigsberg N; Rados M; Simić G
    Coll Antropol; 2008 Jan; 32 Suppl 1():199-204. PubMed ID: 18405083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total tau protein in cerebrospinal fluid and diffusion-weighted MRI as an early diagnostic marker for Creutzfeldt-Jakob disease.
    Satoh K; Shirabe S; Tsujino A; Eguchi H; Motomura M; Honda H; Tomita I; Satoh A; Tsujihata M; Matsuo H; Nakagawa M; Eguchi K
    Dement Geriatr Cogn Disord; 2007; 24(3):207-12. PubMed ID: 17690553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sporadic Creutzfeldt-Jakob disease without dementia at onset: clinical features, laboratory tests and sequential diffusion MRI (in an autopsy-proven case).
    Pauri F; Amabile G; Fattapposta F; Pierallini A; Bianco F
    Neurol Sci; 2004 Oct; 25(4):234-7. PubMed ID: 15549511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autopsy-proven Creutzfeldt-Jakob disease in a patient with a negative 14-3-3 assay and nonspecific EEG and MRI.
    Donahue JE; Hanna PA; Hariharan S
    Neurol Sci; 2004 Feb; 24(6):411-3. PubMed ID: 14767688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias.
    Riemenschneider M; Wagenpfeil S; Vanderstichele H; Otto M; Wiltfang J; Kretzschmar H; Vanmechelen E; Förstl H; Kurz A
    Mol Psychiatry; 2003 Mar; 8(3):343-7. PubMed ID: 12660807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of cerebrospinal fluid proteins as early diagnostic markers for sporadic Creutzfeldt-Jakob disease.
    Pennington C; Chohan G; Mackenzie J; Andrews M; Will R; Knight R; Green A
    Neurosci Lett; 2009 May; 455(1):56-9. PubMed ID: 19429106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of 14-3-3beta immunoblot and T-tau/P-tau ratio in clinically suspected Creutzfeldt-Jakob disease.
    Blennow K; Johansson A; Zetterberg H
    Int J Mol Med; 2005 Dec; 16(6):1147-9. PubMed ID: 16273298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI in the diagnosis of sporadic Creutzfeldt-Jakob disease: a study on inter-observer agreement.
    Tschampa HJ; Kallenberg K; Urbach H; Meissner B; Nicolay C; Kretzschmar HA; Knauth M; Zerr I
    Brain; 2005 Sep; 128(Pt 9):2026-33. PubMed ID: 15958503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desmoplakin as a potential candidate for cerebrospinal fluid marker to rule out 14-3-3 false positive rates in sporadic Creutzfeldt-Jakob disease differential diagnosis.
    Gawinecka J; Ciesielczyk B; Sanchez-Juan P; Schmitz M; Heinemann U; Zerr I
    Neurodegener Dis; 2012; 9(3):139-44. PubMed ID: 22213780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sporadic Creutzfeldt-Jakob disease: clinical and diagnostic characteristics of the rare VV1 type.
    Meissner B; Westner IM; Kallenberg K; Krasnianski A; Bartl M; Varges D; Bösenberg C; Kretzschmar HA; Knauth M; Schulz-Schaeffer WJ; Zerr I
    Neurology; 2005 Nov; 65(10):1544-50. PubMed ID: 16221949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid-optimized two-dimensional difference gel electrophoresis (2-D DIGE) facilitates the differential diagnosis of Creutzfeldt-Jakob disease.
    Brechlin P; Jahn O; Steinacker P; Cepek L; Kratzin H; Lehnert S; Jesse S; Mollenhauer B; Kretzschmar HA; Wiltfang J; Otto M
    Proteomics; 2008 Oct; 8(20):4357-66. PubMed ID: 18814332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSF neurofilament proteins levels are elevated in sporadic Creutzfeldt-Jakob disease.
    van Eijk JJ; van Everbroeck B; Abdo WF; Kremer BP; Verbeek MM
    J Alzheimers Dis; 2010; 21(2):569-76. PubMed ID: 20555148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronological changes in MRI and CSF biochemical markers in Creutzfeldt-Jakob disease patients.
    Satoh K; Shirabe S; Eguchi H; Tsujino A; Motomura M; Satoh A; Tsujihata M; Eguchi K
    Dement Geriatr Cogn Disord; 2007; 23(6):372-81. PubMed ID: 17389797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease.
    Van Everbroeck B; Boons J; Cras P
    Clin Neurol Neurosurg; 2005 Aug; 107(5):355-60. PubMed ID: 16023527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subtype and regional regulation of prion biomarkers in sporadic Creutzfeldt-Jakob disease.
    Llorens F; Zafar S; Ansoleaga B; Shafiq M; Blanco R; Carmona M; Grau-Rivera O; Nos C; Gelpí E; Del Río JA; Zerr I; Ferrer I
    Neuropathol Appl Neurobiol; 2015 Aug; 41(5):631-45. PubMed ID: 25134744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion-weighted MRI in Creutzfeldt-Jakob disease: a better diagnostic marker than CSF protein 14-3-3?
    Mendez OE; Shang J; Jungreis CA; Kaufer DI
    J Neuroimaging; 2003 Apr; 13(2):147-51. PubMed ID: 12722497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of diagnostic criteria for sporadic creutzfeldt-jakob disease among rapidly progressive dementia.
    Tagliapietra M; Zanusso G; Fiorini M; Bonetto N; Zarantonello G; Zambon A; Ermani M; Monaco S; Manara R; Cagnin A
    J Alzheimers Dis; 2013; 34(1):231-8. PubMed ID: 23207489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features and diagnosis of the MM2 cortical subtype of sporadic Creutzfeldt-Jakob disease.
    Krasnianski A; Meissner B; Schulz-Schaeffer W; Kallenberg K; Bartl M; Heinemann U; Varges D; Kretzschmar HA; Zerr I
    Arch Neurol; 2006 Jun; 63(6):876-80. PubMed ID: 16769870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissociation between CSF total tau and tau protein phosphorylated at threonine 231 in Creutzfeldt-Jakob disease.
    Buerger K; Otto M; Teipel SJ; Zinkowski R; Blennow K; DeBernardis J; Kerkman D; Schröder J; Schönknecht P; Cepek L; McCulloch C; Möller HJ; Wiltfang J; Kretzschmar H; Hampel H
    Neurobiol Aging; 2006 Jan; 27(1):10-5. PubMed ID: 16298235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of established and proposed sporadic Creutzfeldt-Jakob disease variants.
    Appleby BS; Appleby KK; Crain BJ; Onyike CU; Wallin MT; Rabins PV
    Arch Neurol; 2009 Feb; 66(2):208-15. PubMed ID: 19204157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.